Vivos Therapeutics (VVOS) Revenue & Revenue Breakdown
Vivos Therapeutics Revenue Highlights
Latest Revenue (Y)
$17.44M
Latest Revenue (Q)
$6.78M
Main Segment (Y)
Service
Vivos Therapeutics Revenue by Period
Vivos Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $17.44M | 16.05% |
| 2024-12-31 | $15.03M | 8.91% |
| 2023-12-31 | $13.80M | -13.87% |
| 2022-12-31 | $16.02M | -5.10% |
| 2021-12-31 | $16.89M | 29.23% |
| 2020-12-31 | $13.07M | 14.68% |
| 2019-12-31 | $11.39M | 200.43% |
| 2018-12-31 | $3.79M | - |
Vivos Therapeutics generated $17.44M in revenue during NA 2025, up 16.05% compared to the previous quarter, and up 133.50% compared to the same period a year ago.
Vivos Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $6.78M | 77.57% |
| 2025-06-30 | $3.82M | 26.66% |
| 2025-03-31 | $3.02M | -18.44% |
| 2024-12-31 | $3.70M | -4.20% |
| 2024-09-30 | $3.86M | -4.79% |
| 2024-06-30 | $4.05M | 18.57% |
| 2024-03-31 | $3.42M | 5.26% |
| 2023-12-31 | $3.25M | -1.61% |
| 2023-09-30 | $3.30M | -2.77% |
| 2023-06-30 | $3.40M | -11.98% |
| 2023-03-31 | $3.86M | -2.35% |
| 2022-12-31 | $3.95M | -6.97% |
| 2022-09-30 | $4.25M | 1.48% |
| 2022-06-30 | $4.18M | 20.92% |
| 2022-03-31 | $3.46M | -21.26% |
| 2021-12-31 | $4.39M | -3.33% |
| 2021-09-30 | $4.55M | 1.09% |
| 2021-06-30 | $4.50M | 30.42% |
| 2021-03-31 | $3.45M | 4.26% |
| 2020-12-31 | $3.31M | 0.47% |
| 2020-09-30 | $3.29M | 0.62% |
| 2020-06-30 | $3.27M | 2.34% |
| 2020-03-31 | $3.20M | 4.61% |
| 2019-12-31 | $3.06M | -7.84% |
| 2019-09-30 | $3.32M | 32.06% |
| 2019-06-30 | $2.51M | -0.00% |
| 2019-03-31 | $2.51M | - |
Vivos Therapeutics generated $6.78M in revenue during Q3 2025, up 77.57% compared to the previous quarter, and up 167.32% compared to the same period a year ago.
Vivos Therapeutics Revenue Breakdown
Vivos Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Sponsorship Seminar Other | $1.22M | $1.94M | - | - | - |
| Service | $10.96M | $7.16M | - | - | - |
| Product | $6.49M | $7.87M | - | - | - |
| Appliances | $3.28M | $5.60M | - | - | - |
| Billing Intelligence Services | $686.00K | $840.00K | - | - | - |
| VIP | $491.00K | $2.48M | - | - | - |
| Treatment Centers | $2.18M | - | - | - | - |
| Center Revenue | - | - | $189.00K | $561.00K | $480.00K |
| Management Service Revenue | - | - | - | $63.00K | $313.00K |
Vivos Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 25: Service (43.31%), Product (25.64%), Appliances (12.95%), Treatment Centers (8.61%), Sponsorship Seminar Other (4.83%), Billing Intelligence Services (2.71%), and VIP (1.94%).
Quarterly Revenue by Product
| Product/Service | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VIP | $56.00K | $82.00K | $130.00K | $223.00K | - | $926.00K | $1.17M | $907.00K | - | - | - | - | - | - | - | - | - | - |
| Appliances | - | $1.41M | $1.03M | $1.27M | $1.30M | $1.58M | $1.58M | $1.15M | - | - | - | - | - | - | - | - | - | - |
| Billing Intelligence Services | $131.00K | $184.00K | $190.00K | $181.00K | $196.00K | $206.00K | $213.00K | $225.00K | - | - | - | - | - | - | - | - | - | - |
| Product | $594.00K | $2.19M | $1.89M | $1.81M | $2.27M | $1.96M | $1.98M | $1.67M | - | - | - | - | - | - | - | - | - | - |
| Service | $3.23M | $4.59M | $1.94M | $1.20M | $1.43M | $1.90M | $2.08M | $1.75M | - | - | - | - | - | - | - | - | - | - |
| Sponsorship Seminar Other | $286.00K | $608.00K | $328.00K | $1.30M | $294.00K | $224.00K | $122.00K | - | - | - | - | - | - | - | - | - | - | - |
| Treatment Centers | $858.00K | $1.32M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Sponsorship/Seminar/Other | - | $236.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Center Revenue | - | - | - | - | - | - | - | - | $90.00K | $25.00K | $50.00K | $105.00K | $219.00K | $186.00K | $135.65K | $134.49K | $118.09K | $91.77K |
| Management Service Revenue | - | - | - | - | - | - | - | - | - | $574.00K | $-19.00K | $11.00K | $40.00K | $24.00K | $90.00K | $90.00K | $74.00K | - |
Vivos Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Service (62.66%), Treatment Centers (16.64%), Product (11.52%), Sponsorship Seminar Other (5.55%), Billing Intelligence Services (2.54%), and VIP (1.09%).
Vivos Therapeutics Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|
| Center Revenue | $50.00K | $105.00K | $219.00K | $186.00K | $135.65K | $134.49K | $118.09K | $91.77K |
| Management Service Revenue | $-19.00K | $11.00K | $40.00K | $24.00K | $90.00K | $90.00K | $74.00K | - |
Vivos Therapeutics's latest quarterly revenue breakdown by geography, as of Dec 22: Center Revenue (161.29%), and Management Service Revenue (-61.29%).
Vivos Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ALUR | Allurion | $32.11M | $2.66M |
| VVOS | Vivos Therapeutics | $17.44M | $6.78M |
| ANL | Adlai Nortye | $5.00M | $2.50M |
| OSRH | OSR | $2.91M | $1.14M |
| LPCN | Lipocine | $1.98M | $114.57K |
| CODX | Co-Diagnostics | $622.49K | $162.91K |
| COCH | Envoy Medical | $241.00K | $42.00K |
| NVNO | enVVeno Medical | - | - |
| AEMD | Aethlon Medical | - | - |
| ADGM | Adagio Medical | - | - |